bioRxivImmunologyPreprint
The Manganese Salt (MnJ) Functions as A Potent Universal Adjuvant
R. Zhang, C. Wang, Y. GuaniD, X. Wei, M. Sha, M. Jing, M. Lv, J. Xu, Y. Wan, Z. Jiang
Abstract
Aluminum adjuvants have been used for a century in various vaccines due to its ability to potentiate humoral immunity and safety records since 1920s. Manganese is an essential micronutrient required for diverse biological activities in cells. We previously found that Mn2+ is a strong type I-interferon stimulator activating the cGAS-STING pathway. Herein we report that a colloidal manganese salt (MnJ) is a potent adjuvant to induce both humoral and cellular immune responses, particularly CTL activation. When administrated intranasally, MnJ was also a strong mucosal adjuvant, inducing high levels of IgA antibodies. MnJ strongly promoted dendritic cell maturation and antigen-specific T cell activation. Interestingly, IL-1/-18 induction and release by Mn2+-activated ASC-mediated inflammasomes were not observed. MnJ showed great adjuvant effects to all tested antigens including inactivated viruses, recombinant proteins and peptides by either intramuscular or intranasal immunization. These findings may have implications in developing potent but safe Mn2+-containing vaccines.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Combinational adjuvants delivered by ink-jet potentiate naked mRNA vaccines for robust protection against infectious diseases
Nan Qiao, Junichi Ishikawa, … Satoshi Uchida·bioRxiv·Dec 27, 2025
- MAIT cells activate dendritic cells to promote T follicular helper cell differentiation and humoral immunity
T. E. Pankhurst, K. H. Buick, … L. M. Connor·bioRxiv·Mar 31, 2022
- mRNA-Encoded TLR5 Agonist as an Immune Adjuvant
Alexandra V. Vylegzhanina, Oscar Murillo Gomez, … Andrei V. Gudkov·bioRxiv·Jun 1, 2026
- Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza virus vaccine adjuvanted with bacterial cell membrane-derived adjuvants
Kirill Vasilev, Irene Hoxie, … Florian Krammer·bioRxiv·Feb 26, 2025
- DDO-adjuvanted influenza A virus nucleoprotein mRNA vaccine induces robust humoral and cellular type 1 immune responses and protects mice from challenge
Victoria Gnazzo, Hanaa Saleh, … Carolina B. López·mBioPeer-reviewed·Dec 18, 2024
- Matrix-M(R) adjuvant triggers inflammasome activation and enables antigen cross-presentation through induction of lysosomal membrane permeabilization
Behdad Zarnegar, Berit Carow, … Carolina Lunderius-Andersson·npj VaccinesPeer-reviewed·Aug 5, 2025